Association of leucine and other branched chain amino acids with clinical outcomes in malnourished inpatients: a secondary analysis of the randomized clinical trial EFFORT.
Journal
European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070
Informations de publication
Date de publication:
08 Sep 2024
08 Sep 2024
Historique:
received:
12
06
2024
accepted:
02
09
2024
revised:
30
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
8
9
2024
Statut:
aheadofprint
Résumé
The essential branched-chain amino acids leucine, isoleucine and valine are considered anabolic and stimulate protein synthesis in the muscles as well in the liver. They also promote muscle recovery and contribute to glucose homeostasis. Recent studies in critically ill patients have demonstrated that depletion of plasma leucine is associated with increased mortality, but data in the non-critical care setting is lacking. This secondary analysis of the randomized controlled Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT), investigated the impact of leucine, isoleucine, and valine metabolism on clinical outcomes. The primary endpoint was 180-day all-cause mortality. Among 238 polymorbid patients with available metabolite measurements, low serum leucin levels were associated with a doubled risk of 180-day all-cause mortality in a fully adjusted regression model (adjusted HR 2.20 [95% CI 1.46-3.30], p < 0.001). There was also an association with mortality for isoleucine (1.56 [95% CI 1.03-2.35], p = 0.035) and valine (1.69 [95% CI 1.13-2.53], p = 0.011). When comparing effects of nutritional support on mortality in patients with high and low levels of leucine, there was no evidence of significant differences in effectiveness of the intervention. The same was true for isoleucine and valine. Our data suggest that depletion of leucine, isoleucine, and valine among malnourished polymorbid patients is associated with increases in long-term mortality. However, patients with low metabolite levels did not show a pronounced benefit from nutritional support. Further research should focus on the clinical effects of nutritional support in patients with depleted stores of essential branched-chain amino acids. clinicaltrials.gov as NCT02517476 (registered 7 August 2015).
Sections du résumé
BACKGROUND
BACKGROUND
The essential branched-chain amino acids leucine, isoleucine and valine are considered anabolic and stimulate protein synthesis in the muscles as well in the liver. They also promote muscle recovery and contribute to glucose homeostasis. Recent studies in critically ill patients have demonstrated that depletion of plasma leucine is associated with increased mortality, but data in the non-critical care setting is lacking.
METHODS
METHODS
This secondary analysis of the randomized controlled Effect of early nutritional support on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT), investigated the impact of leucine, isoleucine, and valine metabolism on clinical outcomes. The primary endpoint was 180-day all-cause mortality.
RESULTS
RESULTS
Among 238 polymorbid patients with available metabolite measurements, low serum leucin levels were associated with a doubled risk of 180-day all-cause mortality in a fully adjusted regression model (adjusted HR 2.20 [95% CI 1.46-3.30], p < 0.001). There was also an association with mortality for isoleucine (1.56 [95% CI 1.03-2.35], p = 0.035) and valine (1.69 [95% CI 1.13-2.53], p = 0.011). When comparing effects of nutritional support on mortality in patients with high and low levels of leucine, there was no evidence of significant differences in effectiveness of the intervention. The same was true for isoleucine and valine.
CONCLUSION
CONCLUSIONS
Our data suggest that depletion of leucine, isoleucine, and valine among malnourished polymorbid patients is associated with increases in long-term mortality. However, patients with low metabolite levels did not show a pronounced benefit from nutritional support. Further research should focus on the clinical effects of nutritional support in patients with depleted stores of essential branched-chain amino acids.
CLINICAL TRIAL REGISTRATION
BACKGROUND
clinicaltrials.gov as NCT02517476 (registered 7 August 2015).
Identifiants
pubmed: 39245679
doi: 10.1038/s41430-024-01507-8
pii: 10.1038/s41430-024-01507-8
doi:
Banques de données
ClinicalTrials.gov
['NCT02517476']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Tsou YL, Wang CH, Chen WS, Wu HP, Liu MH, Lin HC, et al. Combining phenylalanine and leucine levels predicts 30-day mortality in critically Ill patients better than traditional risk factors with multicenter validation. Nutrients 2023;15:649.
doi: 10.3390/nu15030649
pubmed: 36771356
pmcid: 9921772
Holeček M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab. 2018;15:33.
doi: 10.1186/s12986-018-0271-1
Wang MY, Wang CH, Chen WS, Chu CM, Wu HP, Liu MH, et al. U-shape relationship between plasma leucine level and mortality in the intensive care unit. Dis Mark. 2022;2022:7389258.
Mann G, Mora S, Madu G, Adegoke OAJ. Branched-chain amino acids: catabolism in skeletal muscle and implications for muscle and whole-body metabolism. Front Physiol. 2021;2021:12
Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 2018;19:954.
doi: 10.3390/ijms19040954
pubmed: 29570613
pmcid: 5979320
Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ. Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids. 2010;38:1533–9.
doi: 10.1007/s00726-009-0377-x
pubmed: 19882215
Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, et al. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clin Nutr. 2016;35:18–26.
doi: 10.1016/j.clnu.2015.12.010
pubmed: 26797412
Komar B, Schwingshackl L, Hoffmann G. Effects of leucine-rich protein supplements on anthropometric parameter and muscle strength in the elderly: a systematic review and meta-analysis. J Nutr Health Aging. 2015;19:437–46.
doi: 10.1007/s12603-014-0559-4
pubmed: 25809808
Schuetz P, Seres D, Lobo DN, Gomes F, Kaegi-Braun N, Stanga Z. Management of disease-related malnutrition for patients being treated in hospital. Lancet 2021;398:1927–38.
doi: 10.1016/S0140-6736(21)01451-3
pubmed: 34656286
Imoberdorf R, Meier R, Krebs P, Hangartner PJ, Hess B, Staubli M, et al. Prevalence of undernutrition on admission to Swiss hospitals. Clin Nutr. 2010;29:38–41.
doi: 10.1016/j.clnu.2009.06.005
pubmed: 19573958
Reisinger AC, Posch F, Hackl G, Marsche G, Sourij H, Bourgeois B, et al. Branched-chain amino acids can predict mortality in ICU sepsis patients. Nutrients 2021;13:3106.
doi: 10.3390/nu13093106
pubmed: 34578983
pmcid: 8469152
Schuetz P, Fehr R, Baechli V, Geiser M, Deiss M, Gomes F, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet 2019;393:2312–21.
doi: 10.1016/S0140-6736(18)32776-4
pubmed: 31030981
Schuetz P, Fehr R, Baechli V, Geiser M, Gomes F, Kutz A, et al. Design and rationale of the effect of early nutritional therapy on frailty, functional outcomes and recovery of malnourished medical inpatients trial (EFFORT): a pragmatic, multicenter, randomized-controlled trial. Int J Clin Trials. 2018;5:142–50.
doi: 10.18203/2349-3259.ijct20182085
Wunderle C, von Arx D, Mueller SC, Bernasconi L, Neyer P, Tribolet P, et al. Association of glutamine and glutamate metabolism with mortality among patients at nutritional risk-a secondary analysis of the randomized clinical trial EFFORT. Nutrients 2024;16:222.
doi: 10.3390/nu16020222
pubmed: 38257115
pmcid: 10821126
Wunderle C, Siegenthaler J, Seres D, Owen-Michaane M, Tribolet P, Stanga Z, et al. Adaptation of nutritional risk screening tools may better predict response to nutritional treatment: a secondary analysis of the randomized controlled trial Effect of early nutritional therapy on Frailty, Functional Outcomes, and Recovery of malnourished medical inpatients Trial (EFFORT). Am J Clin Nutr. 2024;119:800–8.
doi: 10.1016/j.ajcnut.2024.01.013
pubmed: 38290574
Stumpf F, Wunderle C, Ritz J, Bernasconi L, Neyer P, Tribolet P, et al. Prognostic implications of the arginine metabolism in patients at nutritional risk: A secondary analysis of the randomized EFFORT trial. Clin Nutr. 2024;43:660–73.
doi: 10.1016/j.clnu.2024.01.012
pubmed: 38309228
Ritz J, Wunderle C, Stumpf F, Laager R, Tribolet P, Neyer P, et al. Association of tryptophan pathway metabolites with mortality and effectiveness of nutritional support among patients at nutritional risk: secondary analysis of a randomized clinical trial. Front Nutr. 2024;11:1335242.
doi: 10.3389/fnut.2024.1335242
pubmed: 38425485
pmcid: 10902466
Haenggi E, Kaegi-Braun N, Wunderle C, Tribolet P, Mueller B, Stanga Z, et al. Red blood cell distribution width (RDW) - A new nutritional biomarker to assess nutritional risk and response to nutritional therapy? Clin Nutr. 2024;43:575–85.
doi: 10.1016/j.clnu.2024.01.001
pubmed: 38242035
Kaegi-Braun N, Tribolet P, Baumgartner A, Fehr R, Baechli V, Geiser M, et al. Value of handgrip strength to predict clinical outcomes and therapeutic response in malnourished medical inpatients: secondary analysis of a randomized controlled trial. Am J Clin Nutr. 2021;114:731–40.
doi: 10.1093/ajcn/nqab042
pubmed: 33829236
Bounoure L, Gomes F, Stanga Z, Keller U, Meier R, Ballmer P, et al. Detection and treatment of medical inpatients with or at-risk of malnutrition: suggested procedures based on validated guidelines. Nutrition 2016;32:790–8.
doi: 10.1016/j.nut.2016.01.019
pubmed: 27160498
Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc EWG. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321–36.
doi: 10.1016/S0261-5614(02)00214-5
pubmed: 12765673
Weinberger KM. Einsatz von Metabolomics zur Diagnose von Stoffwechselkrankheiten. Ther Umsch. 2008;65:487–91.
doi: 10.1024/0040-5930.65.9.487
pubmed: 18791962
Yet I, Menni C, Shin SY, Mangino M, Soranzo N, Adamski J, et al. Genetic influences on metabolite levels: a comparison across metabolomic platforms. PLoS ONE. 2016;11:e0153672.
doi: 10.1371/journal.pone.0153672
pubmed: 27073872
pmcid: 4830611
Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, Prehn C, et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet. 2010;42:137–41.
doi: 10.1038/ng.507
pubmed: 20037589
Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Feve B, et al. The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. PLoS ONE. 2017;12:e0173615.
doi: 10.1371/journal.pone.0173615
pubmed: 28278231
pmcid: 5344496
Lau C-HE, Siskos AP, Maitre L, Robinson O, Athersuch TJ, Want EJ, et al. Determinants of the urinary and serum metabolome in children from six European populations. BMC Med. 2018;16:202.
doi: 10.1186/s12916-018-1190-8
pubmed: 30404627
pmcid: 6223046
Jacob M, Lopata AL, Dasouki M, Abdel Rahman AM. Metabolomics toward personalized medicine. Mass Spectrom Rev. 2019;38:221–38.
doi: 10.1002/mas.21548
pubmed: 29073341
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.
pubmed: 14258950
Liu X. Classification accuracy and cut point selection. Stat Med. 2012;31:2676–86.
doi: 10.1002/sim.4509
pubmed: 22307964
Petrie A, Sabin C. Medical statistics at a glance. 4th ed. Hoboken, NJ: Wiley-Blackwell; 2020.
Holecek M. Why are branched-chain amino acids increased in starvation and diabetes? Nutrients 2020;12:3087.
doi: 10.3390/nu12103087
pubmed: 33050579
pmcid: 7600358
Huang SS, Lin JY, Chen WS, Liu MH, Cheng CW, Cheng ML, et al. Phenylalanine- and leucine-defined metabolic types identify high mortality risk in patients with severe infection. Int J Infect Dis. 2019;85:143–9.
doi: 10.1016/j.ijid.2019.05.030
pubmed: 31170548
Chen L, Chen Y, Wang X, Li H, Zhang H, Gong J, et al. Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis. Nutr J. 2015;14:67.
doi: 10.1186/s12937-015-0056-6
pubmed: 26155840
pmcid: 4496824
Teymoori F, Ahmadirad H, Jahromi MK, Mokhtari E, Farhadnejad H, Mohammadzadeh M, et al. Serum branched amino acids and the risk of all-cause mortality: a meta-analysis and systematic review. Amino Acids. 2023;55:1475–86.
doi: 10.1007/s00726-023-03329-7
pubmed: 37725184
Lee SY, Lee HJ, Lim JY. Effects of leucine-rich protein supplements in older adults with sarcopenia: a systematic review and meta-analysis of randomized controlled trials. Arch Gerontol Geriatr. 2022;102:104758.
doi: 10.1016/j.archger.2022.104758
pubmed: 35777246
Wunderle C, Gomes F, Schuetz P, Stumpf F, Austin P, Ballesteros-Pomar MD, et al. ESPEN practical guideline: Nutritional support for polymorbid medical inpatients. Clin Nutr. 2024;43:674–91.
doi: 10.1016/j.clnu.2024.01.008
pubmed: 38309229
Marik PE. Feeding critically ill patients the right ‘whey’: thinking outside of the box. A personal view. Ann Intens Care. 2015;5:51.
doi: 10.1186/s13613-015-0051-2
Marik PE. Nutritional support among medical inpatients-feed the cold (and malnourished) and starve the febrile. JAMA Netw Open. 2019;2:e1915707.
doi: 10.1001/jamanetworkopen.2019.15707
pubmed: 31747027
Cardenas D, Ochoa JB. A paradigm shift in clinical nutrition. Clin Nutr. 2023;42:380–3.
doi: 10.1016/j.clnu.2023.01.014
pubmed: 36739757